Hookworm vaccines will primarily affect the larval stage of the parasitic worm by inducing the production of IgG antibodies. These antibodies will prevent larval development, reducing the population of larvae that develop into adult worms. This will lower mortality rates by preventing the adult hookworms from entering the host’s gastrointestinal tract and producing intestinal blood loss.